To test the hypothesis that MMP-9 expression is associated with MAPK pathway modulation, induced by the treatment with BRAF inhibitors, A375 and A2058 melanoma cells harboring BRAFV600E mutation were used. This evidence concerns the gene MMP9 and melanoma.